p53 polymorphism in codon 72 and risk of human papillomavirus-induced cervical cancer: Effect of inter-laboratory variation

International Journal of Cancer

Volumn 87, Issue 4, 2000, Pages 528-533

  Makni, Hela ^a   Franco, Eduardo L ^a   Kaiano, Jane ^b   Villa, Luisa L ^b   Labrecque, Sylvie ^a   Dudley, Roy ^c   Storey, Alan ^c   Matlashewski, Greg ^a  

^a MCGILL UNIVERSITY   (Canada)

^b LUDWIG INSTITUTE FOR CANCER RESEARCH   (Brazil)

^c IMPERIAL CANCER RESEARCH FUND   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN P53;

ADULT; AGED; ARTICLE; CANCER RISK; CODON; CONTROLLED STUDY; FEMALE; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; HUMAN TISSUE; LABORATORY; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; TUMOR SUPPRESSOR GENE; UTERINE CERVIX CARCINOMA; VIRUS CARCINOGENESIS; WART VIRUS;

ADULT; AGED; ARGININE; CASE-CONTROL STUDIES; COCARCINOGENESIS; CODON; FEMALE; GENES, P53; GENOTYPE; HUMANS; MIDDLE AGED; OBSERVER VARIATION; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; POLYMORPHISM, GENETIC; REPRODUCIBILITY OF RESULTS; RISK FACTORS; TUMOR SUPPRESSOR PROTEIN P53; TUMOR VIRUS INFECTIONS; UTERINE CERVICAL NEOPLASMS;

EID: 0033896465     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/1097-0215(20000815)87:4<528::AID-IJC11>3.0.CO;2-O     Document Type: Article

References (32)

1. Genital human papilloma-virus infection in female university students as determined by a PCR-based method
2. Is p53 polymorphism maintained by natural selection?
3. Papillomavirus and p53 codon 72 polymorphism
4. Adenovirus E1A, simian virus 40 tumor antigen, and human papillomavirus E7 protein share the capacity to disrupt the interaction between transcription factor E2F and the retinoblastoma gene product
5. Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumors
6. The human papilloma virus-16 E7 oncoprotein is able to bind to the retinoblastoma gene product
7. Transmission of cervical human papillomavirus infection by sexual activity: Differences between low and high oncogenic risk types
8. p53 polymorphism and risk of cervical cancer
9. p53 polymorphism and risk of cervical cancer
10. Persistence of type-specific human papillomavirus infection among cytologically normal women
11. Cloning and expression of the cDNA for E6-AP, a protein that mediates the interaction of the human papillomavirus E6 oncoprotein with p53
12. Higher lung cancer risk for African-Americans with the Pro/Pro p53 genotype
13. p53 polymorphism and risk of cervical cancer
14. Loss of heterozygosity on chromosome 17p and mutant p53 in HPV-negative cervical carcinomas
15. Germ line polymorphisms of p53 and CYP1A1 genes involved in human lung cancer
16. No evidence of p53 allele-specific predisposition in human papillomavirus-associated cervical cancer
17. Cancer. p53, guardian of the genome
18. p53 polymorphism and risk of cervical cancer
19. p53, the cellular gatekeeper for growth and division
20. Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms
21. Primary structure polymorphism at amino acid residue 72 of human p53
22. No evidence of correlation between polymorphism at codon 72 of p53 and risk of cervical cancer in Japanese patients with papillomavirus 16/18 infection
23. p53 codon 72 polymorphism and risk of cervical cancer in UK
24. The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes degradation of p53
25. Role of a p53 polymorphism in the development of human papillomavirus-associated cancer
26. Two polymorphic variants of wild-type p53 differ biochemically and biologically
27. Induction of apoptosis by p53 is independent of its oligomeric state and can be abolished by HPV-18 E6 through ubiquitin mediated degradation
28. Determination of the allelic frequencies of an L-myc and a p53 polymorphism in human lung cancer
29. Codon 72 polymorphism of p53 and its association with cervical cancer
30. Polymorphism at codon 72 of the p53 gene in a human acute myelogenous leukemia